Hospital readmissions have long been a concern for healthcare leaders, but the latest Medicare payment adjustments are bringing renewed attention to the financial and clinical consequences of patients returning to the hospital shortly after discharge.

For fiscal year (FY) 2027, the Centers for Medicare & Medicaid Services (CMS) is reducing Medicare payments to 2,334 hospitals, representing approximately 80% of hospitals evaluated under the Hospital Readmissions Reduction Program (HRRP). Of those hospitals, 244 will experience payment reductions of at least 1%, compared with 240 hospitals in FY 2026. Only 578 hospitals avoided a penalty, down from 641 the previous year.

These figures raise an important question for healthcare leaders: Are organizations doing enough to understand why patients return to the hospital, and what could be done differently to prevent avoidable readmissions?

While the financial penalties attract attention, the underlying issue extends beyond reimbursement. Readmissions may reveal opportunities to improve discharge planning, clinical communication, follow-up care, medication management, and coordination among healthcare providers.

Understanding the Financial Impact

The Hospital Readmissions Reduction Program was established to encourage hospitals to reduce potentially avoidable readmissions and improve the quality and coordination of patient care.

CMS evaluates 30-day unplanned readmissions associated with six conditions and procedures:

  • Acute myocardial infarction (heart attack)
  • Chronic obstructive pulmonary disease (COPD)
  • Heart failure
  • Pneumonia
  • Coronary artery bypass graft surgery
  • Elective total hip or total knee replacement

Hospitals with higher-than-expected readmission rates may receive Medicare payment reductions of up to 3%. These reductions apply to applicable Medicare fee-for-service base operating diagnosis-related group payments throughout the fiscal year, not merely to the claims associated with readmitted patients.

For example, a hospital receiving $50 million annually in applicable Medicare inpatient base operating payments could lose approximately $500,000 with a 1% payment reduction.

That financial impact makes readmission performance an organizational concern, not simply a quality department measure.

What Is Different in FY 2027?

Two significant changes to the program deserve attention.

First, CMS now incorporates Medicare Advantage patient data alongside traditional Medicare fee-for-service data when calculating excess readmission ratios. This provides a broader view of hospital performance, although the resulting payment reductions continue to apply only to traditional Medicare payments.

Second, CMS shortened the performance measurement period from three years to two years. FY 2027 penalties reflect hospital discharges occurring between July 1, 2023, and June 30, 2025.

The shorter period allows performance measurements to reflect more recent care practices. It also reinforces the importance of continually reviewing clinical outcomes rather than relying solely on annual quality reports.

Because the methodology changed, healthcare leaders should use caution when comparing current results with earlier years. A change in a hospital’s penalty does not necessarily mean its clinical performance improved or declined by the same amount.

Looking Beyond the Readmission Rate

A readmission does not automatically indicate inappropriate care, and not every return to the hospital can or should be prevented. Patients with complex medical conditions may experience unavoidable complications despite receiving appropriate treatment.

The more important question is whether the organization has a reliable process for identifying potentially preventable readmissions and understanding the circumstances surrounding them.

Consider a patient with heart failure who is discharged home after a hospital stay. The patient’s discharge instructions recommend a follow-up appointment, medication changes, and daily monitoring of weight and symptoms.

Ten days later, the patient returns to the emergency department with worsening symptoms and is readmitted.

A meaningful review should consider more than whether discharge instructions were documented. It should examine whether the patient understood the instructions, obtained the prescribed medications, had a follow-up appointment arranged, and knew whom to contact when symptoms changed.

The review might identify an opportunity to strengthen medication reconciliation, improve communication with an outpatient provider, or establish a clearer process for contacting high-risk patients following discharge.

These are operational and clinical issues that require coordinated attention across departments.

Five Areas Healthcare Leaders Should Review

1. Discharge Planning and Patient Education

Effective discharge planning begins before the patient leaves the hospital.

Organizations should assess whether discharge instructions are individualized, clearly communicated, and appropriate for the patient’s health literacy, clinical needs, and support system.

Documentation should reflect not only what instructions were provided but also how the patient’s understanding was assessed.

2. Medication Reconciliation and Follow-Up Care

Medication discrepancies and gaps in follow-up care may contribute to avoidable complications.

Healthcare leaders should consider whether patients can obtain prescribed medications, whether medication changes are clearly communicated to the next provider, and whether appropriate follow-up appointments have been arranged.

When a follow-up appointment cannot be scheduled before discharge, organizations should have a reliable process to address that gap.

3. Communication Across Care Settings

Transitions from hospitals to skilled nursing facilities (SNFs), home health agencies, rehabilitation providers, or outpatient practices create opportunities for information to be delayed, incomplete, or misunderstood.

Discharge summaries, medication lists, pending test results, and instructions for monitoring changes in condition should be communicated promptly to the appropriate providers.

Hospital leaders should also consider whether they have established relationships and feedback processes with post-acute care organizations serving their patients.

4. Root Cause Analysis of Readmissions

Reviewing readmission numbers is important, but the numbers alone rarely explain what happened.

Organizations should establish a consistent approach to examining potentially preventable readmissions. Reviews might explore:

  • Whether changes in the patient’s condition were identified and addressed promptly
  • Whether discharge instructions were clear and understood
  • Whether the patient experienced barriers to obtaining medications or follow-up care
  • Whether communication between providers was timely and complete
  • Whether the clinical record supports the discharge decisions and services provided
  • Whether similar issues are appearing across multiple patients or departments

The purpose is not to assign blame. It is to identify patterns that might otherwise go unnoticed.

5. Leadership Accountability and Corrective Action

Identifying a problem is only the beginning. Sustainable improvements require clear expectations, assigned responsibilities, and follow-through.

Hospitals should periodically evaluate whether corrective actions have been implemented and whether those changes are producing measurable results.

Clinical, quality, compliance, case management, and operational leaders should have a shared understanding of readmission trends and their respective responsibilities for improvement.

The Role of Post-Acute Care Providers

Hospitals do not manage patient outcomes in isolation.

SNFs and other post-acute providers play an important role in recognizing changes in condition, communicating with physicians, managing medications, and coordinating care.

When a patient is transferred back to the hospital, both organizations have an opportunity to examine whether earlier intervention or improved communication might have changed the outcome.

Joint reviews of selected readmissions can help identify gaps in handoffs, clinical escalation procedures, and expectations for communicating changes in patient condition.

A stronger relationship between hospitals and post-acute providers can support better transitions and a more coordinated approach to patient care.

Preparing for What Comes Next

Healthcare organizations should also be aware that CMS finalized an additional readmission measure involving patients hospitalized with sepsis.

CMS will provide confidential early-look reports during FY 2028 and FY 2029 before incorporating the measure into payment reduction calculations beginning in FY 2030.

Although the financial implications are several years away, organizations can begin evaluating how they manage transitions and follow-up care for patients recovering from sepsis.

This is an opportunity to strengthen existing processes before another measure becomes part of the program’s payment calculations.

Turning Readmission Data Into Meaningful Improvement

The increase in hospitals receiving readmission penalties reinforces an important lesson: collecting quality data is not the same as using it effectively.

Hospitals should understand which conditions are contributing to their excess readmissions, investigate recurring clinical and operational issues, and evaluate whether their corrective actions are making a difference.

An effective review combines data analysis with clinical record review, examination of care transitions, staff interviews when appropriate, and evaluation of existing policies and procedures.

For healthcare leaders, the goal should not be limited to reducing a Medicare penalty. It should be to create reliable processes that support appropriate care, reduce avoidable hospital returns, and improve the patient experience.

The most useful question is not simply how many patients returned to the hospital, but what those readmissions can teach the organization about the care it provides.

Understanding the reasons behind the numbers is where meaningful improvement begins.

LW Consulting, Inc. (LWCI) offers a comprehensive range of services to assist your organization in maintaining compliance, identifying trends, providing education and training,  or conducting documentation and coding audits. For more information, contact LWCI to connect with one of our experts! 

Sources:
Centers for Medicare & Medicaid Services. (2026). Hospital Readmissions Reduction Program: Fiscal Year 2027 Fact Sheet. https://www.cms.gov/files/document/fy-2027-hrrp-fact-sheet-pdf.pdf
Centers for Medicare & Medicaid Services. (2026). Hospital Readmissions Reduction Program. https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/hospital-readmissions-reduction-program-hrrp
Centers for Medicare & Medicaid Services. (2026, July 31). FY 2027 Hospital Inpatient Prospective Payment System and Long-Term Care Hospital Prospective Payment System Final Rule (CMS-1849-F). https://www.cms.gov/newsroom/fact-sheets/fy-2027-hospital-inpatient-prospective-payment-system-long-term-care-hospital-prospective-payment
Centers for Medicare & Medicaid Services. (2026). FY 2027 Hospital Readmissions Reduction Program Payment Reduction Methodology Infographic. https://www.cms.gov/files/document/fy-2027-hrrp-infographic-pdf.pdf
Scheetz, M. (2026, October 7). CMS penalizes 2,334 hospitals for high readmissions: 6 things to know. Becker’s Hospital Review. https://www.beckershospitalreview.com/finance/cms-penalizes-2334-hospitals-for-high-readmissions-6-things-to-know/
Parduhn, R. P. (2026, October 8). Medicare penalizes more hospitals for readmissions. Healthcare Dive. https://www.healthcaredive.com/news/hospital-readmission-reduction-program-penalties-rise-2027-cms/832473/
Centers for Medicare & Medicaid Services. (2026). FY 2027 IPPS Final Rule Home Page. https://www.cms.gov/medicare/payment/prospective-payment-systems/acute-inpatient-pps/fy-2027-ipps-final-rule-home-page